DescriptionIM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel, followed by Germany.
Corporate earnings are provided from Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.
Latest Press Releases
|Period||Period Low||Period High||Performance|
|1-Month|| 3.870 +5.43% increase |
| 4.830 -15.53% decrease |
| +0.200 (+5.15%) increase |
|3-Month|| 3.390 +20.35% increase |
| 6.670 -38.83% decrease |
| -2.360 (-36.65%) decrease |
|52-Week|| 3.390 +20.35% increase |
| 14.400 -71.67% decrease |
| -3.040 (-42.70%) decrease |